205 related articles for article (PubMed ID: 15541000)
1. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
[TBL] [Abstract][Full Text] [Related]
2. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
[TBL] [Abstract][Full Text] [Related]
3. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):131-5. PubMed ID: 15530662
[TBL] [Abstract][Full Text] [Related]
6. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
7. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
8. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
[TBL] [Abstract][Full Text] [Related]
9. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
[TBL] [Abstract][Full Text] [Related]
11. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
12. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains.
Imamura K; Hishikawa N; Ono K; Suzuki H; Sawada M; Nagatsu T; Yoshida M; Hashizume Y
Acta Neuropathol; 2005 Feb; 109(2):141-50. PubMed ID: 15619128
[TBL] [Abstract][Full Text] [Related]
14. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
15. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein, Abeta and Alzheimer's disease.
Wirths O; Bayer TA
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
[TBL] [Abstract][Full Text] [Related]
17. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
Spies PE; Melis RJ; Sjögren MJ; Rikkert MG; Verbeek MM
J Alzheimers Dis; 2009; 16(2):363-9. PubMed ID: 19221426
[TBL] [Abstract][Full Text] [Related]
19. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
